Vanda Pharmaceuticals (VNDA) Misses Q4 EPS by 1c
Tweet Send to a FriendGet Alerts VNDA Hot Sheet
Price: $6.58 +19.64%
EPS Growth %: +46.4%
Financial Fact:
Licensing agreement: 6.61M
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: +46.4%
Financial Fact:
Licensing agreement: 6.61M
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade VNDA Now!
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) reported Q4 EPS of ($0.23), $0.01 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $7.9 million versus the consensus estimate of $8.6 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Vanda Pharmaceuticals, Inc. (VNDA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- ReneSola Ltd. (SOL) Posts Q1 Loss of 45c/ADS; Guides Q2, FY13 Shipments
- Autodesk, Inc. (ADSK) Misses Q1 EPS by 3c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
